IriSys Overview
- Founded
-
1996
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50.2M
IriSys General Information
Description
Provider of pharmaceutical drug services intended for pharmaceutical formulation development. The company provides contract pharmaceutical product development and manufacturing services, specializing in formulation development, cGMP manufacturing of clinical trial materials, commercial pharmaceutical products and consulting related to the drug development process.
Contact Information
Website
www.irisys.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 6828 Nancy Ridge Drive
- Suite 100
- San Diego, CA 92121
- United States
+1 (858) 000-0000
IriSys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 13-Aug-2021 | $50.2M | 00.00 | 000.00 | Completed | Generating Revenue |
| 2. Debt - PPP | 01-May-2020 | 00.00 | Completed | Generating Revenue | ||
| 1. Seed Round | 11-Feb-2015 | $6.3M | $6.3M | Completed | Generating Revenue |
IriSys Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of pharmaceutical drug services intended for pharmaceutical formulation development. The company provides contr
Pharmaceuticals
San Diego, CA
63
As of 2021
00.00
00.00
0000-00-00
000000&0
00.00
000000
adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000000
San Diego, CA
00
As of 0000
000000&0
000 00
uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
0000000000000
Durham, NC
0000
As of 0000
0000
000000&0
0000
Add Comparison
IriSys Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Formex | Formerly VC-backed | San Diego, CA | 00 | 000000&0 | ||
| 000 000000000 | Formerly VC-backed | Durham, NC | 0000 | 0000 | 000000&0 | 0000 |
| 000000 000000 0000 | Corporate Backed or Acquired | Toronto, Canada | 000 | 000000&0 | ||
| 00000000 000000000 | Private Equity-Backed | North Brunswick, NJ | 00 | 000 | 0000000 0000 | 000 |
| 00000000 | Formerly PE-Backed | Morristown, NJ | 0000 | 000000&0 |
IriSys Executive Team (6)
IriSys Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Connelly | Self | Board Member | 000 0000 |
| Jin Wang Ph.D | IriSys | Vice President, Quality Control & Regulatory Filings & Board Member | 000 0000 |
| Luo Ying | Self | Board Member | 000 0000 |
| Robert Giannini | IriSys | President, Board Member and Chief Scientific & Technical Officer | 000 0000 |
| Tom Eastling | Self | Board Member | 000 0000 |
IriSys Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
